title: Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes.
authors.affiliation: Transgene S.A., Strasbourg, France.
authors.forename: P
authors.initials: P
authors.lastname: Leroy
authors.forename: P
authors.initials: P
authors.lastname: Slos
authors.forename: H
authors.initials: H
authors.lastname: Homann
authors.forename: P
authors.initials: P
authors.lastname: Erbs
authors.forename: Y
authors.initials: Y
authors.lastname: Poitevin
authors.forename: E
authors.initials: E
authors.lastname: Regulier
authors.forename: F Q
authors.initials: FQ
authors.lastname: Colonna
authors.forename: P
authors.initials: P
authors.lastname: Devauchelle
authors.forename: C
authors.initials: C
authors.lastname: Roth
authors.forename: A
authors.initials: A
authors.lastname: Pavirani
authors.forename: M
authors.initials: M
authors.lastname: Mehtali
mesh_terms: D000256:Adenoviridae; D000818:Animals; D016207:Cytokines / Q000235:genetics / Q000276:immunology*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy; D007267:Injections; D051379:Mice; D009369:Neoplasms / Q000628:therapy*
chemical_list: D016207:Cytokines